KEYS vs LAB
Keysight Technologies Inc (KEYS) versus Standard Biotools Inc (LAB) — a side-by-side from cached financials, not a winner call.
Keysight Technologies Inc (KEYS) is a scientific & technical instruments company listed on US.
Standard Biotools Inc (LAB) is a medical devices company listed on NASDAQ.
Latest reported KEYS revenue for 2024-10-31 was $4.98B. Net income was $614.0M. Revenue was down 8.9% from 2023-10-31 to 2024-10-31. KEYS currently screens at market cap $59.84B and trailing P/E 56.5.
Latest reported LAB revenue for 2024-12-31 was $174.4M. Net income was -$138.9M. Revenue was up 64.0% from 2023-12-31 to 2024-12-31. LAB currently screens at market cap $317.1M.
KEYS currently screens at market cap $59.84B and trailing P/E 56.5. LAB currently screens at market cap $317.1M.
Not investment advice. Open the KEYS and LAB stock pages for the full models.
Not investment advice.